رسانه خبری غذا و دارو
کانال خبری مجله غذا و دارو رسانهای برای انتشار اخبار و اطلاعات صنعت داروسازی، اخبار همایش و نمایشگاهها و ارائه گزارشهای آماری و تحلیلی جهت انجام تبليغات در كانال به آیدی زیر پیام دهید: @fdsh20
Show more📈 Analytical overview of Telegram channel رسانه خبری غذا و دارو
Channel رسانه خبری غذا و دارو (@fdmag) in the Farsi language segment is an active participant. Currently, the community unites 10 791 subscribers, ranking 2 544 in the Medicine category and 29 258 in the Iran region.
📊 Audience metrics and dynamics
Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 10 791 subscribers.
According to the latest data from 10 June, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by -21 over the last 30 days and by -3 over the last 24 hours, overall reach remains high.
- Verification status: Not verified
- Engagement rate (ER): The average audience engagement rate is 15.54%. Within the first 24 hours after publication, content typically collects 7.28% reactions from the total number of subscribers.
- Post reach: On average, each post receives 1 677 views. Within the first day, a publication typically gains 786 views.
- Reactions and interaction: The audience actively supports content: the average number of reactions per post is 4.
- Thematic interests: Content is focused on key topics such as دارو, صنعت, محصول, نمایشگاه, متخصص.
📝 Description and content policy
The author describes the resource as a platform for expressing subjective opinions:
“کانال خبری مجله غذا و دارو
رسانهای برای انتشار اخبار و اطلاعات صنعت داروسازی، اخبار همایش و نمایشگاهها و ارائه گزارشهای آماری و تحلیلی
جهت انجام تبليغات در كانال به آیدی زیر پیام دهید:
@fdsh20”
Thanks to the high frequency of updates (latest data received on 11 June, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.
Available now! Telegram Research 2025 — the year's key insights 
